Literature DB >> 21236309

Evidence of neutrophil functional defect despite inflammation in stable cirrhosis.

Giovanni Tritto1, Zois Bechlis2, Vanessa Stadlbauer3, Nathan Davies2, Rubén Francés4, Naina Shah2, Rajeshwar P Mookerjee2, Jose Such4, Rajiv Jalan5.   

Abstract

BACKGROUND & AIMS: Deranged neutrophil function in alcoholic hepatitis has been shown to be transmissible to normal neutrophils by patient plasma. The aims of this study were (i) to evaluate whether patients with stable cirrhosis have a similar transmissible neutrophil defect and (ii) to explore the possible mechanisms.
METHODS: Plasma samples from 108 stable cirrhotic patients (Child A or B: 58; Child C: 50) and matched controls were incubated with normal neutrophils. Neutrophil resting respiratory burst, phagocytosis, and toll-like receptors 2, 4, and 9 expressions as well as plasma endotoxin, bacterial DNA, and cytokines were measured. In a separate study, eight patients and five controls were studied using a novel 'skin-window' technique to evaluate neutrophil function in an area of induced sterile inflammation.
RESULTS: Patient plasma induced neutrophil phagocytic dysfunction was greater in patients with more severe disease and was associated with increased expression of toll-like receptors 2 and 4. An increased resting respiratory burst was observed in a subset of patients, showing higher levels of inflammatory cytokines and more pronounced phagocytic impairment. No correlation was found with endotoxemia or bacterial DNA. In patients with compensated cirrhosis and apparently normal neutrophil function, the 'skin-window' study disclosed a severe phagocytic defect at the site of inflammation. Significantly higher levels of neutrophil elastase and IL-8 were found in the blister fluid.
CONCLUSIONS: Stable cirrhosis is characterized by neutrophil phagocytic dysfunction which may be subtle and only revealed in inflamed peripheral tissues where excessive inflammatory mediators continue to be released.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21236309     DOI: 10.1016/j.jhep.2010.11.034

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  52 in total

1.  Amyloid A in Serum and Ascitic Fluid as a Novel Diagnostic Marker of Spontaneous Bacterial Peritonitis.

Authors:  Rehab Badawi; Muhammad N Asghar; Sherief Abd-Elsalam; Samah A Elshweikh; Tamer Haydara; Sherein M Alnabawy; Mahmoud Elkadeem; Walaa ElKhalawany; Samah Soliman; Reham Elkhouly; Shimaa Soliman; Mona Watany; Mai Khalif; Asem Elfert
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2020

2.  Bacterial meningitis complicating the course of liver cirrhosis.

Authors:  Pasquale Pagliano; Giovanni Boccia; Francesco De Caro; Silvano Esposito
Journal:  Infection       Date:  2017-06-14       Impact factor: 3.553

Review 3.  The role of neutrophils in the development of liver diseases.

Authors:  Ruonan Xu; Huihuang Huang; Zheng Zhang; Fu-Sheng Wang
Journal:  Cell Mol Immunol       Date:  2014-03-17       Impact factor: 11.530

4.  Dysfunction of Circulating Polymorphonuclear Leukocytes and Monocytes in Ambulatory Cirrhotics Predicts Patient Outcome.

Authors:  Konstantina Sargenti; Åsa Johansson; Sara Bertilsson; Inger Mattsby-Baltzer; Daniel Klintman; Evangelos Kalaitzakis
Journal:  Dig Dis Sci       Date:  2016-03-24       Impact factor: 3.199

Review 5.  Bloodstream infections in patients with liver cirrhosis.

Authors:  Michele Bartoletti; Maddalena Giannella; Russell Edward Lewis; Pierluigi Viale
Journal:  Virulence       Date:  2016-02-11       Impact factor: 5.882

Review 6.  Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids.

Authors:  Ikuo Nakamura
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 7.  New treatment options for alcoholic hepatitis.

Authors:  Saggere Muralikrishna Shasthry; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

Review 8.  Novel prevention strategies for bacterial infections in cirrhosis.

Authors:  Kathleen Yan; Guadalupe Garcia-Tsao
Journal:  Expert Opin Pharmacother       Date:  2016-02-23       Impact factor: 3.889

Review 9.  Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.

Authors:  Jane Macnaughtan; Rajiv Jalan
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

Review 10.  Cellular Abnormalities and Emerging Biomarkers in Alcohol-Associated Liver Disease.

Authors:  Ashwani K Singal; Shannon M Bailey
Journal:  Gene Expr       Date:  2018-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.